Neuroscience: Neuralink's breakthrough brain-computer interface technology has once again gained developmental opportunities as the U.S. Food and Drug Administration (FDA) officially approved human trials for the company’s second participant. Meanwhile, the FDA also agreed on a solution to technical issues encountered by the first clinical trial participant.

Information disclosed by Neuralink on May 8th indicates that the brain chip implanted in 29-year-old participant Noland Arbaugh has experienced displacement of several of its electrode threads. These threads, thinner than a strand of hair, with 64 of them having retracted. Despite such challenges, Neuralink has adjusted the algorithm for decoding neuronal signals to compensate for the missing data caused by the disconnected electrodes and successfully restored the indicators for the speed and accuracy with which the participant controlled the computer cursor.

Further reports state that only about 15% of the electrodes in the first participant Arbaugh's brain implant continued to function, with the remaining 85% having shifted, and the majority of the failed circuits are now off. This experience has brought Arbaugh significant emotional fluctuation, and he admits to feeling very frustrated during the process.

Neuralink plans to conduct implant surgery on the second participant in June of this year, with a proposed implantation depth of 8 millimeters in the brain, deeper than Arbaugh's surgical depth of 3-5 millimeters, in an effort to prevent the same problems from recurring. Neuralink's ultimate goal is to implant the device in 10 participants by the end of the year and to explore the potential of brain-computer interface technology through research on different individual populations.

Zoology: The German cockroach (Blattella germanica), one of the most common insects worldwide, has sparked curiosity about their origins. For a long time, scientists have been puzzled by these insects that only appear in human habitats and lack natural living environments.

Recent reports in the journal "Nature" revealed a study published in the "Proceedings of the National Academy of Sciences" that the German cockroach likely originated in South Asia and was widely distributed around the world due to its close association with human living environments. Although in 1776, Swedish biologist Carl Linnaeus first recorded and named the “German cockroach” in Europe, this does not mean that they originated from Germany. In fact, they entered human environments from Germany and spread around the world with human activity.

In an international collaborative study, scientists analyzed the genomes of 281 German cockroaches from 17 countries including Australia and Ethiopia. By comparing the similarities and differences between these genomes, researchers deduced the developmental history of different populations and estimated the approximate time and geographical location of their divergence.

The study revealed that the German cockroach's closest relative is the Asian cockroach Blattela asahinai. This species of cockroach still lives in South Asia. It is speculated that the German cockroach diverged from the Asian cockroach about 2100 years ago and may have started adapting to a diet based on human food in the region of India or Myanmar, thereby embarking on its journey of global spread. Approximately 1200 years ago, with the expansion of trade and warfare in the Islamic caliphates of the Middle East, the German cockroach migrated westward to the region. About 390 years ago, with the rise of international trading companies, the German cockroach spread from South Asia eastward to Southeast Asia. About a century later, the cockroach was brought to Europe, and eventually all around the world.

Research merges genetic information with historical processes to provide us with valuable insights. These insights not only explain the origins and spread of the German cockroach but also offer us new ideas for combating drug-resistant roaches.

In another groundbreaking study, laboratories around the world collaborated under the supervision of artificial intelligence (AI) to enhance the efficiency of chemical synthesis and screening. Six labs with automated synthesis or testing capabilities, located in South Korea, Toronto, Glasgow, the University of British Columbia (UBC), the University of Illinois, and Kyushu, Japan, worked together under the oversight of a cloud-based AI platform. This platform monitored the entire experiment process, learned from it, and provided feedback to the experimenters.

Initially, the laboratories at Glasgow University and UBC were responsible for synthesizing different monomers and sending them to the University of Illinois for automated synthesis of luminescent organic compounds. Next, these organic compounds were sent to Toronto for characterization, and after identifying the best candidates, they were sent back to UBC to establish mass production routes. Finally, these materials were shipped to a lab in Kyushu, Japan, to test their performance.

Such collaboration enabled scientists to rapidly iterate and optimize the products, resulting in the synthesis of 621 new chemical compounds, from which 21 new organic compounds with outstanding luminescent properties were selected. Compared to research outcomes over the past decade, this is a substantial leap forward, pointing the way towards the efficient and pragmatic development of new products in the future.

In the field of neuroscience, a new study has shown that non-invasive spinal cord stimulation can significantly improve arm and hand function impaired due to spinal cord injury. Spinal cord injuries can weaken the connections between the brain and the spinal cord, which are important pathways for regulating neural function. By administering electrical stimulation treatment to the corresponding spinal nerve segments, scientists found it could effectively restore impaired neural functions.

In modern medical innovation, a novel non-invasive technique has shown great potential in restoring arm and hand functions in patients with limb paralysis. The latest clinical trial results, published in the Nature Medicine journal, demonstrated the remarkable therapeutic effects of the non-invasive ARCEX device.

In this study, 60 patients with limb paralysis due to spinal cord injury participated. After a period of two months of standardized rehabilitation training in the clinic, the subjects continued with the same duration of rehabilitation, but with the addition of the ARCEX therapy. The results are striking: out of the 60 patients who completed the trial, 43 experienced significant improvements in strength and function. Additionally, there were improvements in fingertip pinch strength and hand mobility, as well as enhanced sensory perception, which in turn improved their quality of life.

This finding marks ARCEX therapy as a new and effective treatment option for nerve rehabilitation in patients with cervical spine injuries. Breakthroughs have also been made in the field of energy innovation. In a study published in the Device journal, researchers utilized solar receivers to capture solar energy and successfully achieved temperatures exceeding 1000 degrees Celsius.

The production of some materials crucial to modern civilization, such as glass, steel, cement, and ceramics, typically requires manufacturing temperatures exceeding 1000°C. However, traditional production methods heavily rely on fossil fuels, causing environmental pollution. This innovative technology employs translucent materials like quartz as thermal capture devices, effectively utilizing the thermal trap effect, a physical phenomenon that can absorb and retain heat. Results show that when the device is exposed to light intensity equivalent to that from 136 suns, the energy absorber's temperature can reach up to 1050°C, while the other end of the quartz rod remains at 600°C. This achievement not only surpasses previous thermal trap effects but also opens up the possibility of solar energy in high-temperature industrial applications.

Researchers are now working on optimizing this solar thermal capture technology and exploring its applications in industrial production to find cleaner energy solutions. Progress in treating chronic diseases on the one hand, and research on sustainable energy development on the other, are important strides in human technological advancement.

Researchers continue to explore new fields to achieve more significant scientific breakthroughs. They are expanding their explorations to a variety of materials, including a wide range of fluids and gases. In this process, scientists hold a grand goal: to achieve higher temperature limits.

After thorough research into the properties of different substances, it is hoped that knowledge allowing us to utilize these materials more efficiently will be uncovered, thereby advancing science and technology. Higher temperature limits could have a revolutionary impact on energy conversion, storage, and utilization, making this research highly significant.